Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

NCT07493642 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-11-17
Last updated
2026-03-25

Condition(s) studied

Chronic Kidney Disease (CKD)CKD Stage 1-3

Investigational drug(s) / intervention(s)

Multimedia Health EducationStandard Education Group

Multimedia Health Education: Participants in this group will receive a multimedia exercise education program designed for patients with chronic kidney disease (CKD). The program includes instructional videos demonstrating proper exercise techniques, safety guidelines, and motivational content to encourage regular physical activity. The intervention aims to enhance participants' exercise knowledge, physical fitness, and activity levels over a 12-week period.

Standard Education Group: Standard CKD Education

Study summary

This clinical trial aims to determine whether a multimedia educational intervention can effectively improve physical fitness and physical activity levels in patients with chronic kidney disease (CKD), while also evaluating its overall outcomes.

The study primarily seeks to answer the following questions:

* Can multimedia education enhance CKD patients' cardiorespiratory endurance, muscle strength, flexibility, and physical activity levels?
* Do patients receiving multimedia education demonstrate greater improvements in health behavior and fitness compared to those receiving standard education alone?

Researchers will compare a multimedia educational video program with conventional patient education to assess whether the multimedia approach helps patients maintain regular exercise and improve physical performance.

Participants will:

* Be randomly assigned to either the multimedia education group or the standard education group.
* Take part in a 12-week intervention and assessment period.
* Undergo pre- and post-intervention evaluations, including:
* Six-minute walk test, grip strength and chair-stand test, flexibility test, and body composition analysis (BMI, waist-to-hip ratio, InBody).
* Completion of a physical activity questionnaire (IPAQ-C). The findings will be used to evaluate the clinical value of multimedia education in CKD management and to support the development of effective patient exercise education programs.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Conscious adults aged 20 years or older who are literate and able to communicate in Mandarin or Taiwanese. * Diagnosed with chronic kidney disease (CKD) stage 1 to 3b according to the CKD-EPI formula and confirmed by a nephrologist. * Able to operate a mobile device (such as a smartphone, tablet, or computer) and have access to equipment capable of playing multimedia videos; family members or caregivers may assist if necessary. * Able to view and understand multimedia educational video content. Exclusion Criteria: * Individuals with cognitive or psychiatric disorders that prevent understanding or adherence to the exercise program. * Individuals with gait instability or limb amputation who are unable to perform the exercise protocol. * Individuals with poorly controlled cardiovascular disease, such as heart failure, myocardial infarction, angina, arrhythmia, or those who have experienced chest pain during activity or rest within the past three months. * Individuals deemed unsuitable for exercise by their attending physician. * Individuals with poorly controlled diabetes (HbA1C \> 9%) accompanied by retinopathy or foot ulcers.

Primary outcome measure(s)

  • Change in 6-minute walk test distance from baseline to 12 weeks, measured in meters. — Baseline and 12 weeks after intervention

Trial sites (1)

FacilityCityRegionStatus
Fu Jen Catholic University Hospital New Taipei City Taishan District Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07493642 on ClinicalTrials.gov ↗ ← All trials in Taiwan